As per recent reports, it has been revealed that a licensing deal has been signed, which will allow cloud services of Microsoft's Office 365 and Windows Azure to be available in China. Things would not have been possible if the deal would not have been finalized by 21Vianet Group, a local data center service provider.
Both the companies have confirmed the news, and have affirmed that the deal will allow Chinese customers to have direct access to the services of the both the companies. While talking about the deal, Microsoft officials affirmed that the main aim behind entering into the deal was to provide their services to Shanghai municipal government.
Dai Haibo, who is the chairman of the Shanghai Municipal Commission of Economy and Informatization, affirmed, "It's a milestone for Microsoft's cloud business in China, and the Shanghai government's adoption of legal software".
On the other hand, Chen Sheng, who is the CEO of 21Vianet, said that they are quite happy to know that China will have its own local data centers. For now, the cloud services have been initiated in Shanghai, but Microsoft officials affirmed that they have been thinking to extend the services in other cities of the country as well.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).